Effectiveness and safety of modified decompressive craniectomy for traumatic brain injury and its impact on inflammatory mediators and prognosis

Wang Ming-Guo; Dang Shuai; Yan Yu

doi:10.11855/j.issn.0577-7402.1509.2023.0525

您当前的位置：

首页 >

文章列表页 >

Effectiveness and safety of modified decompressive craniectomy for traumatic brain injury and its impact on inflammatory mediators and prognosis

Clinical Research | 更新时间：2023-12-13

- Effectiveness and safety of modified decompressive craniectomy for traumatic brain injury and its impact on inflammatory mediators and prognosis
- Medical Journal of Chinese People′s Liberation Army Vol. 48, Issue 11, Pages: 1338-1343(2023)
- 作者机构：
  
  1.南阳市中心医院神经外科，河南南阳 473000
- 作者简介：
- 基金信息：
  
  the Joint Construction Project of Henan Provincial Medical Science and Technology Research Plan(LHGJ20191470)
- DOI：10.11855/j.issn.0577-7402.1509.2023.0525
  CLC：
扫描看全文
王明国, 党帅, 闫禹. 改良去骨瓣减压术处理创伤性脑损伤的有效性和安全性及对炎性介质水平与预后的影响[J]. 解放军医学杂志, 2023, 48(11): 1338-1343.

Wang Ming-Guo,Dang Shuai,Yan Yu.Effectiveness and safety of modified decompressive craniectomy for traumatic brain injury and its impact on inflammatory mediators and prognosis[J].Medical Journal of Chinese People′s Liberation Army,2023,48(11):1338-1343.
王明国, 党帅, 闫禹. 改良去骨瓣减压术处理创伤性脑损伤的有效性和安全性及对炎性介质水平与预后的影响[J]. 解放军医学杂志, 2023, 48(11): 1338-1343. DOI： 10.11855/j.issn.0577-7402.1509.2023.0525.

Wang Ming-Guo,Dang Shuai,Yan Yu.Effectiveness and safety of modified decompressive craniectomy for traumatic brain injury and its impact on inflammatory mediators and prognosis[J].Medical Journal of Chinese People′s Liberation Army,2023,48(11):1338-1343. DOI： 10.11855/j.issn.0577-7402.1509.2023.0525.

摘要

目的,2,评估改良去骨瓣减压术处理创伤性脑损伤的有效性和安全性及对患者血清炎性介质水平与预后的影响。,方法,2,选择2020年6月－2022年1月南阳市中心医院神经外科收治的82例创伤性脑损伤患者，根据去骨瓣减压手术方式不同分为标准组与改良组，各41例。标准组给予标准去骨瓣减压术，改良组给予改良去骨瓣减压术。比较两组术中出血量，手术时间，住院时间，术前、术后6 h、术后3 d的血清神经元特异性烯醇化酶(NSE)、S-100钙结合蛋白B(S-100β)、C反应蛋白(CRP)、降钙素原(PCT)、白细胞介素-6(IL-6)水平，术后1个月格拉斯哥预后量表(GOS)评分、并发症发生情况及切口愈合等级。,结果,2,与标准组比较，改良组住院时间明显缩短(,P,<,0.05)，术中出血量、手术时间差异无统计学意义(,P,>,0.05)；改良组术后6 h、术后3 d 血清NSE、S-100β和炎性因子CRP、PCT、IL-6水平明显低于标准组(,P,<,0.05)。术后1个月改良组GOS评分预后良好率高于标准组[82.9%(34/41),vs,. 63.4%(26/41)，,P,<,0.05]，并发症发生率低于标准组[2.4%(1/41), vs. ,19.5%(8/41)，,P,<,0.05]，切口愈合分级优于标准组(,P,<,0.05)。,结论,2,改良去骨瓣减压术处理创伤性脑损伤，可减轻脑损伤与手术创伤应激，减少并发症发生，加快患者术后康复进程，提高预后良好率，改善切口愈合分级，有效性与安全性较好。

Abstract

Objective,2,To evaluate the efficacy and safety of modified decompressive craniectomy in treatment of traumatic brain injury and its impact on the serum levels of inflammatory mediators and prognosis.,Methods,2,According to different surgical methods, 82 patients with traumatic brain injury admitted to the department of neurosurgery of Nanyang Central Hospital from June 2020 to January 2022 were divided into standard group (,n,=41) and modified group (,n,=41). The standard group was given standard decompressive craniectomy, and the modified group was given modified decompressive craniectomy. The intraoperative blood loss, operation time and hospital stay, the levels of neuron-specific enolase (NSE), S-100 calcium binding protein B (S-100β), C-reaction protein (CRP), procalcitonin (PCT), and interleukin-6 (IL-6) before operation, 6 hours after operation, and 3 days after operation, Glasgow Outcome Scale (GOS), incidence of complications, and incision healing grade 1 month after operation were compared between two groups.,Results,2,Compared with standard group, the hospital stay was significant shorter in modified group (,P,<,0.05), and intraoperative blood loss and operation time were no significant difference in modified group (,P,>,0.05). At 6 hours and 3 days after operation, the levels of NSE, S-100β, CRP, PCT and IL-6 in modified group were lower than those in standard group (,P,<,0.05). Compared with standard group, the good prognosis rate based of GOS was higher in modified group [82.9% (34/41), vs. ,63.4% (26/41),P,<,0.05]; the total incidence of complications was lower in modified group [2.4%(1/41), vs. ,19.5%(26/41),P,<,0.05]; and the grade of incision healing was better in modified group (,P,<,0.05).,Conclusions,2,Modified decompressive craniectomy in the treatment of traumatic brain injury could reduce stress of brain injury and surgical trauma, and the incidence of complications, help to speed up the postoperative recovery process, improve the rate of good prognosis and the grade of incision healing. Its efficacy and safety is better than standard decompressive craniectomy.

关键词

去骨瓣减压术创伤性脑损伤炎性介质预后安全性

Keywords

decompressive craniectomytraumatic brain injuryinflammatory mediatorsprognosissecurity

references

Hawryluk GWJ, Rubiano AM, Totten AM, et al. Guidelines for the management of severe traumatic brain injury: 2020 update of the decompressive craniectomy recommendations[J]. Neurosurgery, 2020, 87(3): 427-434.

Godoy DA, Rabinstein AA. How to manage traumatic brain injury without invasive monitoring[J]. Curr Opin Crit Care, 2022, 28(2): 111-122.

Kong LZ, Zhang RL, Hu SH, et al. Military traumatic brain injury: a challenge straddling neurology and psychiatry[J]. Military Med Res, 2022, 9(1): 18.

Gantner D, Wiegers E, Bragge P, et al. Decompressive craniectomy practice following traumatic brain injury in comparison with randomized trials: harmonized, multi-center cohort studies in Europe, the United Kingdom, and Australia[J]. J Neurotrauma, 2022, 39(11-12): 860-869.

Cooper DJ, Rosenfeld JV, Murray L, et al. Patient outcomes at twelve months after early decompressive craniectomy for diffuse traumatic brain injury in the Randomized DECRA Clinical Trial[J]. J Neurotrauma, 2020, 37(5): 810-816.

Carney N, Totten AM, O'Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition[J]. Neurosurgery, 2017, 80(1): 6-15.

Boase K, Machamer J, Temkin NR, et al. Central curation of glasgow outcome scale-extended data: lessons learned from TRACK-TBI[J]. J Neurotrauma, 2021, 38(17): 2419-2434.

Iaccarino C, Lippa L, Munari M, et al. Management of intracranial hypertension following traumatic brain injury: a best clinical practice adoption proposal for intracranial pressure monitoring and decompressive craniectomy. Joint statements by the Traumatic Brain Injury Section of the Italian Society of Neurosurgery (SINch) and the Neuroanesthesia and Neurocritical Care Study Group of the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI)[J]. J Neurosurg Sci, 2021, 65(3): 219-238.

Hatamleh MM. Contemporary review on craniectomy and cranioplasty; Part 1: decompressive craniectomy[J]. J Craniofac Surg, 2022, 33(3): 838-841.

Abouhashem S, Eldawoody H. Functional outcome after primary decompressive craniectomy for acute subdural hematoma in severe traumatic brain injury[J]. Turk Neurosurg, 2022, 32(2): 211-220.

Lu VM, Carlstrom LP, Perry A, et al. Prognostic significance of subdural hygroma for post-traumatic hydrocephalus after decompressive craniectomy in the traumatic brain injury setting: a systematic review and meta-analysis[J]. Neurosurg Rev, 2021, 44(1): 129-138.

Li L, Molian VA, Seaman SC, et al. Impact of intracerebral hematoma evacuation during decompressive hemicraniectomy on functional outcomes[J]. Stroke, 2021, 52(3): 1105-1108.

Zhang Y, Qian C, Li F, et al. Effect of controlled stepwise intracranial decompression on patients with severe craniocerebral injury and NIHSS score[J]. J Trauma Surg, 2020, 22(4): 314-315.

张毓, 千超, 李峰, 等. 控制性阶梯式颅内减压术对重型颅脑损伤患者的有效性及NIHSS评分的影响[J]. 创伤外科杂志, 2020, 22(4): 314-315.

Zhang KX, Fang XQ, Cheng B, et al. Analysis of the efficacy of early controlled decompression surgery in the treatment of patients with severe hypertensive intracerebral hemorrhage[J]. J Clin Neurosurg, 2020, 17(4): 434-438.

张开鑫, 方宪清, 程彪, 等. 早期分步控制性减压手术治疗重症高血压脑出血患者的疗效分析[J]. 临床神经外科杂志, 2020, 17(4): 434-438.

Tsaousi GG, Marocchi L, Sergi PG, et al. Early and late clinical outcomes after decompressive craniectomy for traumatic refractory intracranial hypertension: a systematic review and meta-analysis of current evidence[J]. J Neurosurg Sci, 2020, 64(1): 97-106.

Giammattei L, Starnoni D, Maduri R, et al. Implementation of cisternostomy as adjuvant to decompressive craniectomy for the management of severe brain trauma[J]. Acta Neurochir (Wien), 2020, 162(3): 469-479.

Hu W, Guo H, Wang G, et al. Evaluation of the efficacy of decompressive osteotomy with superficial temporal artery preservation in the treatment of patients with severe traumatic brain injury[J]. Chin J Trauma, 2021, 37(5): 410-414.

胡炜, 郭晖, 王刚, 等. 保留颞浅动脉去骨瓣减压术治疗重型创伤性脑损伤患者的疗效评价[J]. 中华创伤杂志, 2021, 37(5): 410-414.

Jeong TS, Yee GT, Lim TG, et al. Efficacy and safety of decompressive craniectomy with non-suture duraplasty in patients with traumatic brain injury[J]. PLoS One, 2020, 15(10): e0232561.

Zhang HJ, Diao ZW, Du CF, et al. Effect of closing the dura mater after standard large bone flap decompression on serum S100β and NSE levels and the incidence of postoperative complications in patients with severe head injury[J]. Hebei Med J, 2021, 27(9): 1540-1544.

张华军, 刁正文, 杜春富, 等. 标准大骨瓣减压后关闭硬脑膜对重型颅脑损伤患者血清S100β NSE水平及术后并发症发生率的影响[J]. 河北医学, 2021, 27(9): 1540-1544.

Wu RN, Wu Y, Yang LX, et al. The value of serum Copeptin, ficolin-3 and NSE levels in assessing the severity of traumatic brain injury in children[J]. J Trauma Surg, 2020, 22(9): 684-688.

吴日暖, 吴用, 杨丽霞, 等. 血清Copeptin、ficolin-3及NSE水平评估儿童创伤性脑损伤伤情严重程度的价值[J]. 创伤外科杂志, 2020, 22(9): 684-688.

Li J, Yang X. Clinical efficacy analysis of modified decompressive craniectomy combined with Xingnaojing injection in the treatment of severe craniocerebral injury[J]. Guizhou Med J, 2020, 44(11): 1758-1759.

李军, 杨鑫. 改良去骨瓣减压术联合醒脑静注射液治疗重度颅脑损伤临床疗效分析[J]. 贵州医药, 2020, 44(11): 1758-1759.

Liu XG, Wang EL, Feng J, et al. Analysis of different indicators and inflammatory factors in cerebrospinal fluid of intracranial infection after severe craniocerebral injury[J]. J Trauma Surg, 2020, 22(6): 419-423.

刘晓刚, 王二玲, 冯娟, 等. 重型颅脑损伤术后颅内感染脑脊液中不同指标和炎症因子水平分析[J]. 创伤外科杂志, 2020, 22(6): 419-423.

Wu J, Cao GB, Yang YP, et al. The value of combined detection of serum CRP, CKBB and MMP-2 in risk stratification of mild traumatic brain injury[J]. Lab Med Clin, 2020, 17(20): 2957-2960.

吴俊, 曹冠柏, 杨以平, 等. 血清CRP、CKBB和MMP-2联合检测对轻型创伤性脑损伤危险分层的价值[J]. 检验医学与临床, 2020, 17(20): 2957-2960.

Wang Y, Liao Y. Serum S100B, IL-1β Study on the correlation between IL-6 level and the degree of injury and prognosis of patients with craniocerebral injury[J]. J North Sichuan Med Coll, 2021, 36(10): 1352-1354, 1394.

王英, 廖英. 血清S100B、IL‑1β、IL-6水平与颅脑损伤患者损伤程度和预后的相关性研究[J]. 川北医学院学报, 2021, 36(10): 1352-1354, 1394.

Views

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effects and mechanism of seawater immersion on transcriptome profiles in mice with traumatic brain injury

Diagnostic value of CCL11 and MK in prognosis of patients with differentiated thyroid carcinoma

Association between NF2 gene polymorphism and susceptibility to meningioma

Advances in pathophysiological study of military traumatic brain injury

Related Author

No data

Related Institution

School of Medicine, South China University of Technology

Department of Neurosurgery, the Sixth Medical Center of Chinese PLA General Hospital

Department of Neurosurgery, the First Medical Center of Chinese PLA General Hospital

Institute of Military Cognition and Brain Sciences, Academy of Military Medical Sciences, Academy of Military Sciences

School of Pharmaceutical Sciences, University of South China

⁰